EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Baseline β-Cell Secretory Reserve and Its Association with Glycaemic Control and Long-Term Outcomes Across Diabetes Phenotypes

Rafał Maciulewski, Angelika Buczyńska-Backiel iD, Anna Zielińska-Maciulewska, Katarzyna Siewko, Adam Krętowski iD, Małgorzata Szelachowska

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27042035 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Rafał Maciulewski und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Diabetology and Internal Medicine, Medical University of Bialystok, 15-276 Bialystok, Poland. Hauptthemen laut MEDLINE: Insulin-Secreting Cells, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1, Glycemic Control. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Białystok, Medical University of Bialystok.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Residual β-cell secretory function plays a central role in diabetes pathophysiology; however, long-term comparative data describing β-cell trajectories from diagnosis across diabetes phenotypes remain limited. In this prospective observational study, 393 adults with newly diagnosed diabetes underwent assessment of fasting and glucagon-stimulated C-peptide at diagnosis. The cohort included individuals with type 1 diabetes mellitus (T1DM), encompassing both classical adult-onset autoimmune diabetes and latent autoimmune diabetes in adults (LADA), as well as individuals with type 2 diabetes mellitus (T2DM). A subgroup of 89 participants underwent follow-up visit after a mean of seven years. Glucagon stimulation testing was not repeated at follow-up in patients with T1DM and LADA for clinical and safety reasons; therefore, longitudinal analyses in these groups are based on fasting C-peptide measurements. At diagnosis, fasting and glucagon-stimulated C-peptide concentrations differed markedly between phenotypes (median fasting C-peptide: 0.87 ng/mL in T1DM, 1.53 ng/mL in LADA, and 2.64 ng/mL in T2DM; stimulated C-peptide: 1.35, 1.86, and 4.60 ng/mL, respectively; all p < 0.001). During follow-up, patients with T1DM exhibited a pronounced decline in fasting C-peptide (from 0.95 to 0.10 ng/mL), whereas individuals with T2DM showed preserved or increased stimulated responses (from 4.37 to 5.46 ng/mL). Participants with LADA displayed intermediate baseline values and a gradual decline in fasting C-peptide (from 1.41 to 0.31 ng/mL). Higher baseline C-peptide concentrations were associated with more favourable long-term metabolic profiles, including lower insulin resistance and better glycaemic control. These findings demonstrate that the early dynamic assessment of β-cell reserve using the glucagon stimulation test complements fasting C-peptide by revealing biologically meaningful heterogeneity in disease trajectories, thereby refining phenotypic classification and prognostic stratification at the time of diabetes diagnosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Insulin-Secreting CellsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1Glycemic ControlHumansFemaleC-PeptideMalePhenotypeGlucagonAdultMiddle AgedBlood GlucoseProspective StudiesFastingLatent Autoimmune Diabetes in Adults

Stichwörter der Autor:innen

C-peptideHOMA-IRLADAdiabetes mellitusglucagon stimulation testinsulin resistanceβ-cell function

Substanzen

C-PeptideGlucagonBlood Glucose

Autor:innen und Institutionen

  • Department of Endocrinology, Diabetology and Internal Medicine, Medical University of Bialystok, 15-276 Bialystok, Poland.
  • Clinical Research Centre, Medical University of Bialystok, 15-276 Bialystok, Poland.

ORCID-Profile: Angelika Buczyńska-Backiel, Adam Krętowski

Förderung

  • Medical University of Białystok
  • Medical University of Bialystok

Zitieren

APA

Maciulewski, R., Buczyńska-Backiel, A., Zielińska-Maciulewska, A., Siewko, K., Krętowski, A., & Szelachowska, M. (2026). Baseline β-Cell Secretory Reserve and Its Association with Glycaemic Control and Long-Term Outcomes Across Diabetes Phenotypes. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27042035

Vancouver

Maciulewski R, Buczyńska-Backiel A, Zielińska-Maciulewska A, Siewko K, Krętowski A, Szelachowska M. Baseline β-Cell Secretory Reserve and Its Association with Glycaemic Control and Long-Term Outcomes Across Diabetes Phenotypes. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27042035

BibTeX
@article{Maciulewski2026,
  author = {Maciulewski, Rafał and Buczyńska-Backiel, Angelika and Zielińska-Maciulewska, Anna and Siewko, Katarzyna and Krętowski, Adam and Szelachowska, Małgorzata},
  title = {Baseline β-Cell Secretory Reserve and Its Association with Glycaemic Control and Long-Term Outcomes Across Diabetes Phenotypes},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27042035}
}
Kostenlos starten →